A recent study showed that inactivating mutations of RSK2 may occur in HCC patients, reducing the negative feedback inhibition of Son of sevenless 1/2 on the Ras/Raf/MAPK signaling pathway and ultimately leading to the proliferation and migration of Hep3B cells. The gene discussed is RPS6KA3; the disease is hepatocellular carcinoma.